<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00549393</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00006799</org_study_id>
    <nct_id>NCT00549393</nct_id>
  </id_info>
  <brief_title>Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit</brief_title>
  <official_title>Impact of Daily Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sage Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to conduct a large clinical study to determine if daily bathing
      with chlorhexidine impregnated cloths will reduce the incidence of healthcare-associated
      infections in the Pediatric Intensive Care Unit (PICU).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bacteremia</measure>
    <time_frame>participants were followed for the duration of ICU stay, median stay 3 days</time_frame>
    <description>incidence of bacteremia comparing those in treatment and control groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Central Line Associated-bloodstream Infection (CLABSI)</measure>
    <time_frame>participants were followed for the duration of ICU stay, median stay 3 days</time_frame>
    <description>Comparing incidence of central line-associated bloodstream infections between treatment and control groups</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Bacteremia</measure>
    <time_frame>duration of ICU stay, median 3 days</time_frame>
    <description>per protocol analysis of incidence of bacteremia comparing those in treatment and control groups</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5659</enrollment>
  <condition>Nosocomial Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily bathing with 2% chlorhexidine gluconate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard bathing with soap and water basin or disposable cloth</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Chlorhexidine gluconate cloth</intervention_name>
    <description>Daily bathing</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in pediatric intensive care unit

        Exclusion Criteria:

          -  Patients with a history of an allergic reaction to chlorhexidine

          -  Patients less than 2 months of age

          -  Patients with severe skin disease or burn

          -  Patients with an indwelling epidural catheter or lumbar drain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Trish M Perl, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aaron Milstone, MD MHS</last_name>
    <role>Study Chair</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM; Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013 Mar 30;381(9872):1099-106. doi: 10.1016/S0140-6736(12)61687-0. Epub 2013 Jan 28.</citation>
    <PMID>23363666</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2007</study_first_submitted>
  <study_first_submitted_qc>October 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2007</study_first_posted>
  <results_first_submitted>March 31, 2015</results_first_submitted>
  <results_first_submitted_qc>September 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 2, 2015</results_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intensive care unit</keyword>
  <keyword>Healthcare associated infections (HAI)</keyword>
  <keyword>pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The hospital ICU units underwent a crossover study design, so the ICUs recruited participants in the assigned treatment or control group, then the unit had a washout period, then the unit switched to the alternative assignment of intervention or control for a separate population of participants that were admitted into the ICU.</recruitment_details>
      <pre_assignment_details>5659 enrolled visits in the study, but 712 were excluded from analysis as they did not meet the eligibility criteria</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>2% Chlorhexidine Gluconate Cloth</title>
          <description>Daily bathing with 2% chlorhexidine gluconate
2% Chlorhexidine gluconate cloth: Daily bathing</description>
        </group>
        <group group_id="P2">
          <title>Standard Bath</title>
          <description>Standard bathing with soap and water basin or disposable cloth</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 (6 Months)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1319">intention to treat (ITT)</participants>
                <participants group_id="P2" count="1199">ITT</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Per Protocol</title>
              <participants_list>
                <participants group_id="P1" count="880"/>
                <participants group_id="P2" count="1199"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1319"/>
                <participants group_id="P2" count="1199"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 2 Washout (2 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 3 (6 Months)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1103">number not equal to period 1 due to unit cross over design</participants>
                <participants group_id="P2" count="1326">number not equal to period 1 due to unit cross over design</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Per Protocol</title>
              <participants_list>
                <participants group_id="P1" count="667"/>
                <participants group_id="P2" count="1326"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1103"/>
                <participants group_id="P2" count="1326"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment Arm</title>
          <description>Daily bathing with 2% chlorhexidine gluconate
2% Chlorhexidine gluconate cloth: Daily bathing</description>
        </group>
        <group group_id="B2">
          <title>Control Arm</title>
          <description>Standard bathing with soap and water basin or disposable cloth</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2422"/>
            <count group_id="B2" value="2525"/>
            <count group_id="B3" value="4947"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.8" lower_limit="1.1" upper_limit="12.9"/>
                    <measurement group_id="B2" value="4.8" lower_limit="1.1" upper_limit="12.7"/>
                    <measurement group_id="B3" value="4.8" lower_limit="1.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1389"/>
                    <measurement group_id="B2" value="1388"/>
                    <measurement group_id="B3" value="2777"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1033"/>
                    <measurement group_id="B2" value="1137"/>
                    <measurement group_id="B3" value="2170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1271"/>
                    <measurement group_id="B2" value="1269"/>
                    <measurement group_id="B3" value="2540"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1151"/>
                    <measurement group_id="B2" value="1256"/>
                    <measurement group_id="B3" value="2407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PRISM III Score</title>
          <description>Severity score that predicts mortality. Range 0 (lowest mortality risk) to 74 (highest mortality risk)</description>
          <units>score</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5" lower_limit="0" upper_limit="13"/>
                    <measurement group_id="B2" value="5" lower_limit="0" upper_limit="11"/>
                    <measurement group_id="B3" value="5" lower_limit="0" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Bacteremia</title>
        <description>incidence of bacteremia comparing those in treatment and control groups</description>
        <time_frame>participants were followed for the duration of ICU stay, median stay 3 days</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Arm</title>
            <description>Daily bathing with 2% chlorhexidine gluconate
2% Chlorhexidine gluconate cloth: Daily bathing</description>
          </group>
          <group group_id="O2">
            <title>Control Arm</title>
            <description>Standard bathing with soap and water basin or disposable cloth</description>
          </group>
        </group_list>
        <measure>
          <title>Bacteremia</title>
          <description>incidence of bacteremia comparing those in treatment and control groups</description>
          <population>Intent to treat population</population>
          <units>events per 1000 at-risk days</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2422"/>
                <count group_id="O2" value="2525"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.52" lower_limit="2.64" upper_limit="4.61"/>
                    <measurement group_id="O2" value="4.93" lower_limit="3.91" upper_limit="6.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central Line Associated-bloodstream Infection (CLABSI)</title>
        <description>Comparing incidence of central line-associated bloodstream infections between treatment and control groups</description>
        <time_frame>participants were followed for the duration of ICU stay, median stay 3 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Arm</title>
            <description>Daily bathing with 2% chlorhexidine gluconate
2% Chlorhexidine gluconate cloth: Daily bathing</description>
          </group>
          <group group_id="O2">
            <title>Control Arm</title>
            <description>Standard bathing with soap and water basin or disposable cloth</description>
          </group>
        </group_list>
        <measure>
          <title>Central Line Associated-bloodstream Infection (CLABSI)</title>
          <description>Comparing incidence of central line-associated bloodstream infections between treatment and control groups</description>
          <units>events per 1000 at-risk days</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2422"/>
                <count group_id="O2" value="2525"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.63" lower_limit="0.87" upper_limit="2.79"/>
                    <measurement group_id="O2" value="3.00" lower_limit="2.00" upper_limit="4.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Bacteremia</title>
        <description>per protocol analysis of incidence of bacteremia comparing those in treatment and control groups</description>
        <time_frame>duration of ICU stay, median 3 days</time_frame>
        <population>Includes per protocol population of 1547 of 2422 in the treatment arm</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>Daily bathing with 2% chlorhexidine gluconate</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Standard bathing with soap and water basin or disposable cloth</description>
          </group>
        </group_list>
        <measure>
          <title>Bacteremia</title>
          <description>per protocol analysis of incidence of bacteremia comparing those in treatment and control groups</description>
          <population>Includes per protocol population of 1547 of 2422 in the treatment arm</population>
          <units>events per 1000 at-risk days</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1547"/>
                <count group_id="O2" value="2525"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.28" lower_limit="2.277" upper_limit="4.58"/>
                    <measurement group_id="O2" value="4.93" lower_limit="3.91" upper_limit="6.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>participants were followed for the duration of ICU stay, median stay 3 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Arm</title>
          <description>Daily bathing with 2% chlorhexidine gluconate
2% Chlorhexidine gluconate cloth: Daily bathing</description>
        </group>
        <group group_id="E2">
          <title>Control Arm</title>
          <description>Standard bathing with soap and water basin or disposable cloth</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2422"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2525"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="2422"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="2525"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin reaction</sub_title>
                <counts group_id="E1" events="43" subjects_affected="43" subjects_at_risk="2422"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="2525"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Aaron Milstone</name_or_title>
      <organization>Johns Hopkins University</organization>
      <phone>4106143917</phone>
      <email>amilsto1@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

